Clinical trial

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

NCT03759392

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Omecamtiv Mecarbil Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-09

PhasePHASE3

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

Omecamtiv MecarbilDRUG

PlaceboDRUG

Sponsors & collaborators

Cytokineticslead sponsor

Mapped research locations

DallasTexas, United States2 MontrealQuebec, Canada2 IndianapolisIndiana, United States2 NaplesItaly2 New YorkNew York, United States1 BostonMassachusetts, United States1 BaltimoreMaryland, United States1 AtlantaGeorgia, United States1 ParisFrance1 ColumbusOhio, United States1 PortlandOregon, United States1 DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03759392 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.